FindTrial
Sign In

Anticoagulation in critically ill patients with isolated distal deep vein thrombosis

Anticoagulation in critically ill patients with isolated distal deep vein thrombosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091716
Enrollment
Unknown
Registered
2024-11-01
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous thromboembolism

Interventions

Anticoagulation group:None
Non-anticoagulation group:None

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Admitted to our intensive care unit (EICU, RICU, CCU, NICU) from June 2022 to September 2023. 2. Aged 18 years old or over. 3. Diagnosed with IDDVT by ultrasound. 4. At least one ultrasound follow-up within two weeks of diagnosis.

Exclusion criteria

Exclusion criteria: 1. Outpatients or emergency patients. 2. Prolonged anticoagulation for other reasons (e.g., atrial fibrillation). 3. Hospitalization in ICU <72 hours. 4. Anticoagulation within 3-14 days of diagnosis of IDDVT. 5. No ultrasound follow-up after diagnosis of IDDVT. 6. Combined proximal deep vein thrombosis or pulmonary embolism. 7. Incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
proximal extension;—

Secondary

MeasureTime frame
proximal deep vein thrombosis;pulmonary embolism;Complete thrombus dissolution;Major bleeding;Clinically relevant non-major bleeding;All-cause mortality;—

Countries

China

Contacts

Public ContactHong Chen

The First Affiliated Hospital of Chongqing Medical University

hopehong2019@126.com+86 186 8080 2072

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026